Europe to face shortage of Eli Lilly diabetes drug Trulicity through September Ruchika Sharma30 Aug 2023 11:30 AM ISTEurope: Europe will continue to face a shortage of Eli Lilly & Co's blockbuster diabetes drug Trulicity through September, the European Medicines...
Retevmo demonstrates superior progression free survival compared to approved Multikinase Inhibitors in RET-Mutant Medullary Thyroid Cancer: Eli Lilly Ruchika Sharma23 Aug 2023 12:30 PM ISTRetevmo is a highly selective and potent RET kinase inhibitor with CNS activity.
Eli Lilly concludes acquisition of Versanis Bio Ruchika Sharma18 Aug 2023 5:14 PM ISTIndianapolis: Eli Lilly and Company has announced the successful completion of its acquisition of Versanis Bio. The acquisition expands...
Eli Lilly concludes acquisition of Sigilon Therapeutics Ruchika Sharma17 Aug 2023 10:00 AM ISTIndianapolis: Eli Lilly and Company has announced the successful completion of its acquisition of Sigilon Therapeutics, Inc. The acquisition...
Eli Lilly concludes acquisition of DICE Therapeutics Ruchika Sharma12 Aug 2023 2:30 PM ISTIndianapolis: Eli Lilly and Company has announced the successful completion of its acquisition of DICE Therapeutics, Inc.. The acquisition...
Eli Lilly sued by Nektar Therapeutics over autoimmune disease treatment Ruchika Sharma8 Aug 2023 1:30 PM ISTUS: Nektar Therapeutics has sued Eli Lilly, accusing the U.S. drugmaker of undermining the prospects for a drug the companies were developing...
Eli Lilly- Boehringer Ingelheim Jardiance gets European Commission nod to treat adults with CKD Ruchika Sharma26 July 2023 4:30 PM ISTIngelheim: The European Commission (EC) has approved Jardiance (empagliflozin) for the treatment of adults with chronic kidney disease (CKD),...
Eli Lilly presents results from Phase 3 trial of Donanemab at Alzheimer's Association Conference Ruchika Sharma19 July 2023 12:39 PM ISTIndianapolis: Eli Lilly and Company has presented full results from the Phase 3 TRAILBLAZER-ALZ 2 study showing that donanemab significantly...
Eli Lilly to acquire Versanis for USD 1.925 billion Ruchika Sharma15 July 2023 1:00 PM ISTIndianapolis: Eli Lilly and Company and Versanis Bio have announced a definitive agreement for Lilly to acquire Versanis, a private...
Eli Lilly to buy Sigilon Therapeutics Ruchika Sharma2 July 2023 1:00 PM ISTIndianapolis: Eli Lilly and Companyand Sigilon Therapeutics, Inc. have announced a definitive agreement for Lilly to acquire Sigilon, a...
Eli Lilly to acquire DICE Therapeutics Ruchika Sharma25 Jun 2023 10:00 AM ISTLilly will commence a tender offer to acquire all outstanding shares of DICE for a purchase price of USD 48 per share in cash payable at closing.
Eli Lilly-Boehringer Ingelheim bags USFDA nod for Type 2 diabetes drugs Jardiance, Synjardy for children Ruchika Sharma21 Jun 2023 4:30 PM ISTUnited States: The U.S. Food and Drug Administration (FDA) on Tuesday approved Eli Lilly and partner Boehringer Ingelheim's drugs Jardiance and...
